October 02, 2025

New IL-23 Inhibitors Expand Treatment Options for Crohn’s Disease

The U.S. Food and Drug Administration has approved two new medications for Crohn’s disease, following the results of successful multisite clinical trials conducted in part at the Icahn School of Medicine at Mount Sinai. The therapies, interleukin-23 inhibitors mirikizumab and guselkumab, fill an important gap in Crohn’s disease treatment.

Mount Sinai New York

October 01, 2025

Shutdown Showdown: How Long Can Health Services Last?

Federal shutdown suspends some health services, limits National Institutes of Health research, and raises questions about Affordable Care Act subsidies, Medicaid, and public health programs.

KFF Health News

September 29, 2025

Clinicians: Ultraprocessed Food Limits Coming to Cafeterias?

States consider bipartisan bans on ultraprocessed foods in schools over obesity and child health.

KFF Health News

September 29, 2025

The 7-Day Risk ACIP Didn't Address

Delaying newborn hepatitis B shots may leave infants exposed to everyday transmission risks.

KFF Health News

September 29, 2025

Intestinal Ultrasound Offers Prognostic Value in IBD Pregnancy

"We rely very little on symptoms in pregnancy—they’re so unreliable—and instead target fecal calprotectin under 100 and sonographic remission."

Conexiant

September 25, 2025

Prolonged therapy in eosinophilic esophagitis prevents relapse without added risk

"Proton pump inhibitors appeared more effective than off-label swallowed topical corticosteroids in sustaining histologic and clinical responses."

Conexiant

September 24, 2025

Medical Oddities: Why Time on the Toilet Matters

From toilets to tea, bones to bullies, medicine’s strangest corners show us where science loves to surprise.

Conexiant

September 24, 2025

Endoscopic surveillance for Barrett's esophagus: Two-year results

"The burden of Barrett’s surveillance on endoscopic resources can be significant, and it may be appropriate to lengthen the surveillance interval or consider offering at-need endoscopy to well-informed patients."

Conexiant

September 24, 2025

Gastric varices: Nonselective beta-blockers may lower mortality

Given the high mortality associated with gastric variceal hemorrhage, ongoing investigation into pharmacologic and interventional approaches remains critical to improving patient outcomes.

Conexiant